Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)

被引：0
作者：
Luisa Klotz
Berit Grützke
Maria Eveslage
Michael Deppe
Catharina C. Gross
Lucienne Kirstein
Anita Posevitz-Fejfar
Tilman Schneider-Hohendorf
Nicholas Schwab
Sven G. Meuth
Heinz Wiendl
机构：
[1] University Hospital Münster,Department of neurology
[2] Westfaelische Wilhelms-University Münster,Institute of biostatistics and clinical research
来源：
BMC Neurology | / 15卷
关键词：
Multiple sclerosis; Natalizumab; Fingolimod; PML; Switching;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Cost-minimization analysis of alemtuzumab compared to fingolimod and natalizumab for the treatment of active relapsing-remitting multiple sclerosis in the Netherlands [J].
Piena, M. A. ;
Heisen, M. ;
Wormhoudt, L. W. ;
van Wingerden, J. ;
Frequin, S. T. F. M. ;
Uitdehaag, B. M. J. .
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (10) :968-976
[32]   Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis [J].
Fruschelli, Mario ;
Capozzoli, Marco ;
Gelmi, Maria Chiara ;
Masi, Gianni ;
Annunziata, Pasquale .
INTERNATIONAL OPHTHALMOLOGY, 2019, 39 (04) :777-781
[33]   Natalizumab Treatment for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia [J].
Algahtani, Hussein ;
Shirah, Bader ;
Abobaker, Hind ;
Alghanaim, Nebras ;
Kamel, Fatemah .
CLINICAL NEUROPHARMACOLOGY, 2018, 41 (06) :199-201
[34]   Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis [J].
Strijbis, Eva M. ;
Coerver, Eline ;
Mostert, Jop ;
van Kempen, Zoe L. E. ;
Killestein, Joep ;
Comtois, Jacynthe ;
Repovic, Pavle ;
Bowen, James D. ;
Cutter, Gary ;
Koch, Marcus .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (10) :792-799
[35]   Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom [J].
Spelman, T. ;
Herring, W. L. ;
Acosta, C. ;
Hyde, R. ;
Jokubaitis, V. G. ;
Pucci, E. ;
Lugaresi, A. ;
Laureys, G. ;
Havrdova, E. K. ;
Horakova, D. ;
Izquierdo, G. ;
Eichau, S. ;
Ozakbas, S. ;
Alroughani, R. ;
Kalincik, T. ;
Duquette, P. ;
Girard, M. ;
Petersen, T. ;
Patti, F. ;
Csepany, T. ;
Granella, F. ;
Grand'Maison, F. ;
Ferraro, D. ;
Karabudak, R. ;
Jose Sa, M. ;
Trojano, M. ;
van Pesch, V. ;
Van Wijmeersch, B. ;
Cartechini, E. ;
Mccombe, P. ;
Gerlach, O. ;
Spitaleri, D. ;
Rozsa, C. ;
Hodgkinson, S. ;
Bergamaschi, R. ;
Gouider, R. ;
Soysal, A. ;
Prevost, J. ;
Garber, J. ;
de Gans, K. ;
Ampapa, R. ;
Simo, M. ;
Sanchez-Menoyo, J. L. ;
Iuliano, G. ;
Sas, A. ;
van der Walt, A. ;
John, N. ;
Gray, O. ;
Hughes, S. ;
De Luca, G. .
JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) :109-125
[36]   Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study [J].
Gajofatto, Alberto ;
Bianchi, Maria Rachele ;
Deotto, Luciano ;
Benedetti, Maria Donata .
EUROPEAN NEUROLOGY, 2014, 72 (3-4) :173-180
[37]   Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis [J].
Langdon, Dawn W. ;
Tomic, Davorka ;
Penner, Iris-Katharina ;
Calabrese, Pasquale ;
Cutter, Gary ;
Haering, Dieter A. ;
Dahlke, Frank ;
Kappos, Ludwig .
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (12) :4135-4145
[38]   Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab [J].
Costa Arpin, Eva ;
Garcia Sobrino, Tania ;
Dominguez Vivero, Clara ;
Amigo Jorrin, Maria del Campo ;
Rodriguez Regal, Ana ;
Prieto Gonzalez, Jose ;
Lema Bouzas, Manuela .
NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (01) :5-12
[39]   Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis [J].
Takahiko Saida ;
Qi Hao ;
Michihiro Kanda ;
Yumiko Tani .
BMC Neurology, 23
[40]   Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis [J].
Saida, Takahiko ;
Hao, Qi ;
Kanda, Michihiro ;
Tani, Yumiko .
BMC NEUROLOGY, 2023, 23 (01)
12345